Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 82 results for "Tecfidera Treated Patients"

Biogen more than halves 2015 outlook guidance as Q2 sales disappoint; shares plummet
Proactive Investors USA

Biogen more than halves 2015 outlook guidance as Q2 sales disa...

2:11 pm by A patient's death on Tecfidera, reported last year, may have alarmed doctors and patients and slowed the drug's growth, Tony Kingsley, Biogen's head of global commercial operations, said on a call with investors. Biogen () tumbled ... Proactive Investors USA, 1 week ago
[x]  

Quebec Government to Cover TECFIDERA as a First-Line Oral Treatment for Multiple Sclerosis

Important Step for those Living with MS in Quebec MISSISSAUGA, ON, June 3, 2015 /CNW/ -Biogen Canada announces today that Quebec's Institut national d'excellence en santé et services sociaux (INESSS) has updated its recommendation for TECFIDERA ...
 Canada NewsWire1 month ago

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Revision: 3, Authorised

This is a summary of the European public assessment report (EPAR) for Tecfidera. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on ...
 European Medicines Agency3 weeks ago

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Rege…

Several major biotech companies like Biogen ( BIIB - Analyst Report ), AbbVie ( ABBV - Analyst Report ), Celgene and Gilead reported second quarter results over the last five trading days. Biogen has been grabbing headlines for the wrong reasons ...
 Zacks.com2 days ago

Regulus snags milestone in MS biomarker deal with Biogen

Regulus Therapeutics ($RGLS) has partnered up with Biogen Idec ($BIIB) to identify microRNA biomarkers in the blood of patients with multiple sclerosis. The California biotech has charted some progress, pocketing a milestone payment and moving ...
 Fierce BioMarkers3 days ago

Biogen (BIIB) Reports Second Non-Fatal Tecfidera PML Case 7/20/2015

July 17, 2015 By Mark Terry , BioSpace.com Breaking News Staff Cambridge, Mass.-based Biogen, Inc. reported yesterday that a second patient taking the company's multiple sclerosis drug Tecfidera (dimethyl fumarate) has developed a ...
 ClinicSpace1 week ago Why All Eyes Will Be on Biogen (BIIB)'s Alzheimer's Data Next Week 7/16/2015  ClinicSpace2 weeks ago Genentech's Ocrelizumab Wows in Late Stages and Eyes $18 Billion MS Market  BioSpace1 month ago Genentech (RHHBY)'s Ocrelizumab Wows in Late Stages and Eyes $18 Billion MS Market 7/1/2015  ClinicSpace4 weeks ago
MedPage Today

Getting a Handle on Lymphopenia With Tecfidera

Action Points Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. A retrospective chart review of 159 MS ...
 MedPage Today1 month ago

No Surprises with Tysabri-Tecfidera Switch

Action Points Note that these studies were published as abstracts and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal. The first study is a postmarketing, ...
 MedPage Today1 month ago

ALKERMES PLC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our condensed consolidated financial statements and related notes beginning on page 5 of this Form 10-Q, and Management's Discussion and Analysis of Financial Condition and Results of ...
 Pharmacy Choice1 day ago

Alkermes' (ALKS) CEO Richard Pops on Q2 2015 Results - Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by and welcome to the Alkermes Conference Call to discuss the company's Second Quarter Financial Results. At this time, all participants are in a listen-only mode. There will be a ...
 Seeking Alpha1 day ago Biogen (BIIB) George A. Scangos, Ph.D. on Q2 2015 Results - Earnings Call Transcript  Seeking Alpha1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less